References
Aoi, T., Yae, K., Nakagawa, M., et al. (2008). Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science DOI 10.1126/science.1154884.
Hanna, J., Wernig, M., Markoulaki, S., et al. (2007). Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science, 318(5858), 1920–1923.
Maherali, N. (2007). Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell, 1, 55–70.
Nakagawa, M., Koyanagi, M., Tanabe, K., et al. (2008). Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nature Biotechnology, 26(1), 101–106.
Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germ line-competent induced pluripotent stem cells. Nature, 448(7151), 313–317.
Takahashi, K., Tanabe, K., Ohnuki, M., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861–872.
Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663–676.
Wernig, M., Meissner, A., Foreman, R., et al. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 448(7151), 318–324.
Yu, J., Vodyanik, M. A., Smuga-Otto, K., et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science, 318(5858), 1917–1920.
Lowry, W. E., Richter, L., Yachechko, R., et al. (2007). Generation of human induced pluripotent stem cells from dermal fibroblasts. Proceedings of the National Academy of Sciences of the United States of America, 105(8), 2883–2888.
Park, I.-H., Zhao, R., West, J., et al. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451, 141–146.
Simonsson, S., & Gurdon, J. (2004). DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nature Cell Biology, 6(10), 984–990.
Jiang, G., Park, K., Kim, J., et al. (2008). Hyaluronic acid–polyethyleneimine conjugate for target specific intracellular delivery of siRNA. Biopolymers, 89(7), 635–642 Jul.
Toh, M. L., Hong, S. S., van de Loo, F., et al. (2005). Enhancement of adenovirus-mediated gene delivery to rheumatoid arthritis synoviocytes and synovium by fiber modifications: role of arginine–glycine–aspartic acid (RGD)- and non-RGD-binding integrins. Journal of Immunology, 175(11), 7687–7698 Dec 1.
Cowan, C. A., Klimanskaya, I., McMahon, J., et al. (2004). Derivation of embryonic stem-cell lines from human blastocysts. New England Journal of Medicine, 350(13), 1353–1356.
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147.
Taylor, C. J., Bolton, E. M., Pocock, S., Sharples, L. D., Pedersen, R. A., & Bradley, J. A. (2005). Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching. Lancet, 366(9502), 2019–2025.
Revazova, E. S., Turovets, N. A., Kochetkova, O. D., et al. (2008). HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. Cloning and Stem Cells, 10(1), 11–24.
Addis, R. C., Bulte, J. W., & Gearhart, J. D. (2008). Special cells, special considerations: the challenges of bringing embryonic stem cells from the laboratory to the clinic. Clinical Pharmacology & Therapeutics, 83(3), 386–389.
Allegrucci, C., & Young, L. E. (2007). Differences between human embryonic stem cell lines. Human Reproduction Update, 13(2), 103–120.
Huber, I., Itzhaki, I., Caspi, O., et al. (2007). Identification and selection of cardiomyocytes during human embryonic stem cell differentiation. FASEB Journal, 21(10), 2551–2563.
Acknowledgement
The authors wish to thank James Byrne, Ph.D. (Stanford Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Palo Alto, CA) and Zeina Saikali, Ph.D. (Juravinski Cancer Centre, Hamilton, Ontario, Canada), for having kindly reviewed the manuscript. The authors also wish to thank Kathleen Gallagher and Brian Habekoss, for having provided excellent administrative support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pappas, J.J., Yang, P.C. Human ESC vs. iPSC—Pros and Cons. J. of Cardiovasc. Trans. Res. 1, 96–99 (2008). https://doi.org/10.1007/s12265-008-9032-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-008-9032-2